The advice is useful as clinicians wait for formal guidelines.
Statin users had 30% increased odds of acute kidney injury and 36% increased odds of chronic kidney disease compared with non-users.
In a study, the arrhythmia was 31% more likely to occur in PKD patients than non-PKD control patients.
Carbamazepine co-treatment linked to subtherapeutic anticoagulative effect of warfarin.
Target levels more likely to be achieved in departments that prescribe more statins.
Follow-up of patients from ACCORD trial shows neutral effect on primary composite outcome.
Increased risk of SCD with electrocardiogram abnormalities, even in normal-weight individuals.
The drugs do not appear to prevent progression to ESRD, new meta-analysis finds.
Overall albuminuria drop may be too small for cardiovascular, renal risk protection.
Review found atrial fibrillation linked to higher risk of stroke, cardiac events, death in women.
Reduction in total primary end point events, driven by reductions in myocardial infarction, stroke.
After adjustment for multiple variables, PP linked to all outcomes except stroke, cardiovascular death.
Serious hypoglycemia linked to progression of CAC only in standard therapy group of VA Diabetes Trial.
180 mg/dL or greater tied to worse outcomes for most patients; not for those with insulin-treated diabetes.
Independent correlation persisted after adjustment for cardiovascular risk factors.
ERN together with statin reduces apoB-48 by lowering fasting and postprandial secretion rate.
Increased left ventricular mass found in donors with even mild decreases in renal function.
Decrease in age-adjusted death rates from 2000 to 2012; increase from 2012 to 2014.
Online communications reduced need for phone calls and office visits for many.
Reductions in risks of major CVD events, coronary heart disease, stroke, and heart failure.
2004 to 2012 saw increase in percutaneous ventricular assist devices, intraaortic balloon pump.
Insufficient evidence for lipid screening in children; recommendation for statins varies with age, risk
No change in primary outcome of change in physical limitation score at 12 months.
Rapid, specific, dose-dependent, reversible inhibition seen in patients with coronary artery disease.
Increased odds of warfarin-associated adverse events in patients for whom INR not measured daily.
Even surgery patients with stage 1 AKI without true organ damage had a 43% increase in cardiovascular mortality risk within 10 years compared with patients with no kidney disease.
Survival significantly higher for patients who call emergency services in response to symptoms.
Researchers observe significant improvements chronic and hemodialysis-induced vascular dysfunction.
Improvement in lipid profile for nutraceuticals alone or in combo for statin-intolerant patients.
Chance of stroke, myocardial infarction increased most in the first week after diagnosis.
Sign Up for Free e-newsletters
NEPHROLOGY & UROLOGY NEWS
- Acute Kidney Injury (AKI)
- Chronic Kidney Disease (CKD)
- Contrast Nephropathy
- Cardiovascular Disease (CVD)
- Diabetic Nephropathy
- End-stage Renal Disease (ESRD)
- Lupus Nephritis
- Peritoneal Dialysis
- Secondary Hyperparathyroidism (SHPT)